1-3 of 3
Tatiana Ionova, DSc
Close
Sort by
Journal Articles

Final Development of the First Generic Quality of Life and Symptoms Measure Specific for Hematological Malignancies: The HM-PRO

Pushpendra Goswami, PhD MSc, BPharm, Tatiana Ionova, DSc, Esther Natalie Oliva, PhD, Roger Else, Jonathan Kell, MD, Adele K. Fielding, MBBS,PhDFRCP,FRCPath, Daniel Jennings, Marina Karakantza, MD, Saad Al-Ismail, MD, Graham P. Collins, MA, MBBS, MRCP, FRCPath, DPhil, Stewart McConnell, Catherine Langton, Sam Salek, PhDRPh FFPM MCMS MRPSGB FESCP
Journal: Blood
Blood (2019) 134 (Supplement_1): 3484.
https://doi.org/10.1182/blood-2019-129030
Published: 2019
Journal Articles

Quality of Life in Chronic Myeloid Leukemia Patients with Deep Molecular Response Who Stopped Therapy By Tyrosine Kinase Inhibitors: Interim Results of Russian Prospective Multicenter Trial RU-SKI

Anna Petrova, MD, Ekaterina Chelysheva, MD PhD, Oleg Shukhov, MD PhD, Anastasiya Bykova, MD, Galina Gusarova, MD PhD, Irina Nemchenko, MD PhD, Nikolay Tsyba, MD PhD, Anna G Turkina, Prof., MD, Tatiana Nikitina, PhD, Natalia Porfirieva, Anna Zinkovskaya, Tatiana Ionova, DSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3023.
https://doi.org/10.1182/blood-2018-99-113360
Published: 2018
Journal Articles

Is Quality of Life (QOL) Predictive for Clinical Response in Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients Treated with Dasatinib?

Tatiana Ionova, DSc, Natalia Bulieva, MD, Anatoly Golenkov, MDProf, Taras Gritsenko, MD, Lilia Kozlova, MD Prof, Galina Kuchma, MD PhD, Elza Lomaia, MD, Elena Machulaytene, MD, Tatiana Nikitina, PhD, Natalia Novitskaya, MD PhD, Elena Usacheva, MD PhD, Tatiana Shneider, MD, Elena Trifonova, MD PhD, Olga Vinogradova, MD PhD, Anna Zinkovskaya
Journal: Blood
Blood (2017) 130 (Supplement 1): 2181.
https://doi.org/10.1182/blood.V130.Suppl_1.2181.2181
Published: 2017